Home › Partnership over acquisition: Could the Juno-Celgene deal be the new norm for biotech?
 

Keywords :   


Partnership over acquisition: Could the Juno-Celgene deal be the new norm for biotech?

2015-07-15 10:44:11| Biotech - Topix.net

When Seattle biotech Juno Therapeutics announced a history-making deal with New Jersey-based Celgene Corp. at the end of June, analysts had mixed reactions.

Tags: the for deal partnership

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Public Advisory Number 36A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
07.07Eastern North Pacific Tropical Weather Outlook
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
More »